Sales változás Dátum
ALKERMES USD 377.48M 3.46M 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amarin USD 74.71M 8.66M 2023-12
ANI Pharmaceuticals USD 131.65M 175K 2023-12
Anika Therapeutics USD 42.97M 1.51M 2023-12
Arrowhead Research USD 3.55M 12.55M 2023-12
Eisai JPY 177.7B 1.09B 2023-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Endo International USD 497.73M 46.07M 2023-12
Esperion Therapeutics USD 32.25M 1.72M 2023-12
GlaxoSmithKline GBP 8.05B 95M 2023-12
Heron Therapeutics USD 34.23M 2.8M 2023-12
Insmed USD 83.69M 4.62M 2023-12
Ligand Pharmaceuticals USD 28.1M 4.77M 2023-12
Merck USD 14.63B 1.33B 2023-12
Nektar Therapeutics USD 23.88M 259K 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Pacira USD 181.24M 17.32M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sangamo BioSciences USD 2.04M 7.36M 2023-12
Surmodics USD 30.55M 2.58M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Veracyte USD 98.2M 8.09M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Heron Therapeutics Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.